Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination - PubMed (original) (raw)

. 2018 Aug;55(8):6237-6249.

doi: 10.1007/s12035-017-0838-2. Epub 2017 Dec 29.

Affiliations

• PMID: 29288338
• DOI: 10.1007/s12035-017-0838-2

Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination

Stefan Esser et al. Mol Neurobiol. 2018 Aug.

Abstract

Multiple sclerosis (MS) is a chronic degenerative disease of the central nervous system that is characterized by myelin abnormalities, oligodendrocyte pathology, and concomitant glia activation. The factors triggering gliosis and demyelination are currently not well characterized. New findings suggest an important role of the innate immune response in the initiation and progression of active demyelinating lesions. Especially during progressive disease, aberrant glia activation rather than the invasion of peripheral immune cells is accountable for progressive neuronal injury. The innate immune response can be induced by pathogen-associated or danger-associated molecular patterns, which are identified by pattern recognition receptors (PRRs), including the Toll-like receptors (TLRs). In this study, we used the cuprizone model in mice to investigate the expression of TLR2 during the course of cuprizone-induced demyelination. In addition, we used TLR2-deficient mice to analyze the functional role of TLR2 activation during cuprizone-induced demyelination and reactive gliosis. We show a significantly increased expression of TLR2 in the corpus callosum and hippocampus of cuprizone-intoxicated mice. The absence of receptor signaling in TLR2-deficient mice resulted in less severe reactive astrogliosis in the corpus callosum and cortex. In addition, microglia activation was ameliorated in the corpus callosum of TLR2-deficient mice, but augmented in the cortex compared to wild-type littermates. Extent of demyelination and loss of mature oligodendrocytes was comparable in both genotypes. These results suggest that the TLR2 orchestrates glia activation during gray and white matter demyelination in the presence of an intact blood-brain barrier. Future studies now have to address the underlying mechanisms of the region-specific TLR2-mediated glia activation.

Keywords: CNS; Cuprizone; Demyelination; Multiple sclerosis; Pattern recognition receptor; Toll-like receptor.

PubMed Disclaimer

Similar articles

• Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
  Bihler K, Kress E, Esser S, Nyamoya S, Tauber SC, Clarner T, Stope MB, Pufe T, Brandenburg LO. Bihler K, et al. J Mol Neurosci. 2017 Jun;62(2):232-243. doi: 10.1007/s12031-017-0924-y. Epub 2017 May 2. J Mol Neurosci. 2017. PMID: 28466255
• The cuprizone model: regional heterogeneity of pathology.
  Wergeland S, Torkildsen Ø, Myhr KM, Mørk SJ, Bø L. Wergeland S, et al. APMIS. 2012 Aug;120(8):648-57. doi: 10.1111/j.1600-0463.2012.02882.x. Epub 2012 Feb 24. APMIS. 2012. PMID: 22779688
• Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.
  Janssen K, Rickert M, Clarner T, Beyer C, Kipp M. Janssen K, et al. Mol Neurobiol. 2016 Apr;53(3):1551-1564. doi: 10.1007/s12035-015-9113-6. Epub 2015 Feb 8. Mol Neurobiol. 2016. PMID: 25663168
• Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination.
  Zirngibl M, Assinck P, Sizov A, Caprariello AV, Plemel JR. Zirngibl M, et al. Mol Neurodegener. 2022 May 7;17(1):34. doi: 10.1186/s13024-022-00538-8. Mol Neurodegener. 2022. PMID: 35526004 Free PMC article. Review.
• Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases.
  Vega-Riquer JM, Mendez-Victoriano G, Morales-Luckie RA, Gonzalez-Perez O. Vega-Riquer JM, et al. Curr Neuropharmacol. 2019;17(2):129-141. doi: 10.2174/1570159X15666170717120343. Curr Neuropharmacol. 2019. PMID: 28714395 Free PMC article. Review.

Cited by

• Pattern Recognition Receptors in Multiple Sclerosis and Its Animal Models.
  Deerhake ME, Biswas DD, Barclay WE, Shinohara ML. Deerhake ME, et al. Front Immunol. 2019 Nov 12;10:2644. doi: 10.3389/fimmu.2019.02644. eCollection 2019. Front Immunol. 2019. PMID: 31781124 Free PMC article. Review.
• Wuzi Yanzong Pill relieves CPZ-induced demyelination by improving the microenvironment in the brain.
  Li YR, Sun MY, Hang W, Xiao Q, Fan HJ, Jia L, Jin XM, Zhang B, Xiao BG, Ma CG, Chai Z. Li YR, et al. Heliyon. 2022 Dec 10;8(12):e12277. doi: 10.1016/j.heliyon.2022.e12277. eCollection 2022 Dec. Heliyon. 2022. PMID: 36578409 Free PMC article.
• From Immunity to Neurogenesis: Toll-like Receptors as Versatile Regulators in the Nervous System.
  Abarca-Merlin DM, Martínez-Durán JA, Medina-Pérez JD, Rodríguez-Santos G, Alvarez-Arellano L. Abarca-Merlin DM, et al. Int J Mol Sci. 2024 May 24;25(11):5711. doi: 10.3390/ijms25115711. Int J Mol Sci. 2024. PMID: 38891900 Free PMC article. Review.
• Inhibition of neutral sphingomyelinase 2 promotes remyelination.
  Yoo SW, Agarwal A, Smith MD, Khuder SS, Baxi EG, Thomas AG, Rojas C, Moniruzzaman M, Slusher BS, Bergles DE, Calabresi PA, Haughey NJ. Yoo SW, et al. Sci Adv. 2020 Oct 2;6(40):eaba5210. doi: 10.1126/sciadv.aba5210. Print 2020 Oct. Sci Adv. 2020. PMID: 33008902 Free PMC article.

References

1. 1. Glia. 2017 Dec;65(12):1900-1913 - PubMed
2. 1. J Neuroendocrinol. 2011 Jul;23(7):601-11 - PubMed
3. 1. J Leukoc Biol. 2008 Nov;84(5):1248-55 - PubMed
4. 1. Clin Exp Immunol. 2010 Oct;162(1):1-11 - PubMed
5. 1. J Mol Neurosci. 2017 Apr;61(4):617-624 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • scite Smart Citations